Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT06316063
Other study ID # 2023-
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 25, 2024
Est. completion date March 25, 2026

Study information

Verified date August 2023
Source Region Stockholm
Contact Malin Jonsson Fagerlund
Phone +46 8 1237000
Email malin.jonsson-fagerlund@regionstockholm.se
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

During apnoeic oxygenation there is a continuous raise in carbon dioxide with subsequent respiratory acidosis. The hypercapnia and respiratory acidosis have several dose-related effects on both the systemic and the pulmonary circulation and the heart that ultimately, if unrecognised, can result in cardiovascular collapse and fatal arrhythmias. In our knowledge, no studies have investigated the haemodynamic effects of apnoeic oxygenation with HFNO. The general purpose of this project is to investigate haemodynamic alternations during apnoeic oxygenation with HFNO compared to mechanical ventilation in relatively healthy patients under general anaesthesia during laryngeal surgery.


Description:

This study aims to investigate and observe the circulatory effects in a patient undergoing apnoeic oxygenation with HFNO during shorter elective laryngeal surgery compared to mechanical ventilation. 20 patients scheduled for elective laryngeal surgery, eligible for apnoeic oxygenation at the Karolinska University Hospital, will be recruited. If eligible, the patient will receive oral and written study information by one of the investigators well in advance of the planned surgery. After a signed consent, the subject will be enrolled and randomised to either apnoeic oxygenation with HFNO or mechanical ventilation. Patient characteristics such as age, sex, weight, height, ASA classification, other comorbidities and airway-related parameters will be documented. A preoperative transthoracic echocardiographic examination and routine perioperative monitoring, will be performed together with a 12-lead ECG. Preoperatively, an arterial catheter will be inserted in the radial artery and an arterial blood gas, measuring PaCO2, PaO2, pH, HCO3 and blood samples of stress markers including catecholamines and other cardiac biomarkers will be collected. The FloTrac system will be connected to the arterial catheter and baseline values will be registered. A peripheral venous catheter is placed prior to anaesthesia and the patient is placed supine. In the apnoeic oxygenation group the HFNO nasal prongs (Optiflow, Fisher & Paykel Healthcare, Auckland, New Zealand) is placed in the nostrils and used for pre-oxygenation, 100 % O2, 40 L/min during 3 min. Thereafter, anaesthesia is induced by intravenous Propofol and Remifentanil administration. Rocuronium for full neuromuscular blockade is administered and a jaw thrust is used to keep an open airway. The start of apnoea is noted, defined as 1 minute after Rocuronium administration. The airway will be kept patent throughout the procedure using a suspension laryngoscope, placed by the ENT surgeon. During apnoea the flow of oxygen is increased to 70 L/min, 100% O2. Apnoea will be discontinued if any of the criteria SpO2 < 90%, PaCO2 >11 kPa, pH <7.15 or arrhythmias with haemodynamic effects occur. In the mechanical ventilation group pre-oxygenation is performed by a tight-fitting facemask, 100 % O2, for three minutes. After anaesthesia induction using intravenous Propofol and Remifentanil and Rocuronium for full neuromuscular blockade, tracheal intubation is performed and mechanical ventilation is started. The start of apnoea is noted. The ventilator is set to PEEP 5 cmH2O, tidal volume (TV) 7 ml/kg ideal body weight, FiO2 0.4, and the respiratory frequency adjusted to reach a PaCO2 of 5,0 -5,3 kPa. Standard perioperative monitoring will be registered (peripheral oxygen saturation, heart rate and MAP). Arterial blood gases will be collected and ECG performed repeatedly. Data from the FloTrac system will be monitored throughout the procedure. Transthoracic echocardiography will be performed regularly. Blood samples to analyse stress markers including catecholamines and cardiac biomarkers will be collected at specific timepoints. At the end of the procedure, any neuromuscular blockade is reversed by Sugammadex. The end of apnoea is defined as reoccurrence of spontaneous breathing or start of mask ventilation. In the mechanically ventilated group, subjects are extubated when awake and responsive. After the procedure and when fully awake, the patient is transferred to the post-operative unit. The FloTrac monitoring will be continued during the postoperative period and the TTE, ECG evaluation, arterial blood gases, stress markers including catecholamines and cardiac biomarkers will be repeated during the post-operative period. Routine postoperative monitoring will be performed for a minimum of 60 minutes.


Recruitment information / eligibility

Status Recruiting
Enrollment 20
Est. completion date March 25, 2026
Est. primary completion date March 25, 2026
Accepts healthy volunteers No
Gender All
Age group 18 Years to 110 Years
Eligibility - Inclusion criteria I. Adult, =18 years old II. ASA 1-2 III. BMI < 30 IV. Planned for elective laryngeal surgery - Exclusion criteria I. NYHA-class >1 II. Pregnancy III. Severe gastric reflux IV. Neuromuscular disease V. Any pulmonary disease VI. Smokers or former smoker, last finished 6 months before inclusion VII. Not capable of understanding study information and signing a written consent

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Apnoeic oxygenation with high-flow nasal oxygen
The subjects in the intervention group will be oxygenated with HFNO during the surgical procedure.
Other:
Mechanical ventilation
Study subjects in the comparator group will be tracheally intubated and mechanically ventilated

Locations

Country Name City State
Sweden Karolinska Universitetssjukhuset Huddinge Stockholm

Sponsors (2)

Lead Sponsor Collaborator
Region Stockholm Karolinska Institutet

Country where clinical trial is conducted

Sweden, 

Outcome

Type Measure Description Time frame Safety issue
Primary Significant haemodynamic effects during apnoeic oxygenation with HFNO Significant haemodynamic effects such as significant increase in mPAP and/or new echocardiographic signs of right ventricular strain or failure compared to baseline, during and up to 2 hours after apnoeic oxygenation with HFNO or mechanical ventilation. 3 hours
Secondary Alterations in FloTrac derived central haemodynamic parameters Alterations in FloTrac derived central haemodynamic parameters such as MAP, SV, SVRI and CI, during and up to 2 hours after apnoeic oxygenation with HFNO or mechanical ventilation. 3 hours
Secondary Alterations in Electrocardiogram Alterations in electrocardiogram during and up to 2 hours after apnoeic oxygenation with HFNO or mechanical ventilation. 3 hours
Secondary Alterations in arterial carbon dioxide, oxygen and pH Alterations in arterial carbon dioxide, oxygen and pH during and up to 2 hours after apnoeic oxygenation with HFNO or mechanical ventilation. 3 hours
Secondary Alterations in blood catecholamines and cardiac biomarkers Alterations in blood catecholamines and cardiac biomarkers during and up to 2 hours after apnoeic oxygenation with HFNO or mechanical ventilation. 3 hours
See also
  Status Clinical Trial Phase
Recruiting NCT05400642 - Randomized Controlled Trial:High-flow Oxygen Therapy and Tracheal Intubation for Laryngeal Microsurgery N/A
Recruiting NCT03429036 - Biospecimen Procurement for Head and Neck Disorders
Completed NCT00001552 - Characteristics of Idiopathic Familial Voice Disorders N/A
Recruiting NCT04777474 - Benefit of Enhanced Contact Endoscopy in Pre-histological Diagnosis of Laryngeal and Hypopharyngeal Mucosal Lesions N/A
Recruiting NCT06303180 - NIDCD Otolaryngology Clinical Protocol Biospecimen Bank
Not yet recruiting NCT03450694 - Role of Ultrasound in Laryngeal Lesions N/A
Recruiting NCT04369040 - Comparison of Two Ventilation Methods for Micro-Laryngeal Surgery N/A
Recruiting NCT05198219 - Procedural Efficiency and Organisational Impact of Rhino Laryngoscopes Procedures in Consults N/A
Completed NCT01507792 - Iron Repletion in Chronic Cough and Iron Deficiency N/A
Completed NCT04231344 - Laryngeal Disorders and GERD in Assiut University
Withdrawn NCT03214835 - CDx Biopsies for Detection of Laryngopharyngeal Reflux and Laryngeal Lesions N/A
Not yet recruiting NCT06078527 - Assessment of Laryngopharyngeal Sensation: Cancer Survivor Cohort N/A